drugset / Trial / NCT00967148
Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer
RandomizedParallel-groupOpen-labelPrevention
Summary
The blood thinner "tinzaparin" might increase survival in patients with colon cancer undergoing surgical resection. The investigators want to assess if a trial allocating patients to prolonged treatment with tinzaparin versus standard of care is feasible.
Timeline
- Start
- 2009-06
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tinzaparin | Other / unclassified | 4500 iu | Subcutaneous |